v3 Template
K

Krystal Biotech

Biotechnology Pittsburgh, Pennsylvania ~420 employees
Founded
--
Employees (Est.)
~420
21 leaders known
Total Funding
$160.0M
Funding Rounds
1
Last Funding
2023-05-22

About Krystal Biotech

Krystal Biotech, Inc. is a commercial-stage company focused on developing and delivering genetic medicines using redosable gene therapies to treat severe, life-threatening, or rare diseases with limited or no approved therapies.

Products & Services

VYJUVEK:The first and only redosable gene therapy for the treatment of dystrophic epidermolysis bullosa.
Pipeline:An extensive pipeline of genetic therapies aimed at correcting the root cause of serious and rare diseases.

Specialties

Genetic Medicines Redosable Gene Therapies Treatment of Rare Diseases HSV-1 Vector Technology Manufacturing of Gene Therapies

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Private Placement
T: -
FT: Private Placement 		A: 160000000
MR: -
FA: $160 million
FAN: 160000000 		D: 2023-05-22
FD: 2023-05-22 		4 investors
Private Placement Latest
2023-05-22
$160.0M
4 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Julian Gangolli

Board Member

K

Krish Krishnan

Chairman & CEO

C

Catherine Mazzacco

Board Member

K

Kirti Ganorkar

Board Member

S

Suma Krishnan

President, Research and Development

D

Dino A. Rossi

Board Member

View 18 more team members with Pro

Unlock Full Team Directory

Recent News

Krystal Biotech Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~420 employees (est.)
Locations
Pittsburgh, Pennsylvania

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro